Study suggests that many small tumors are sleepy, not deadly.
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Mammograms find many slow-growing cancers that aren’t life-threatening and shouldn’t be treated, a Danish study said.